Multiphasic Prehab Allo-HSCT - Trial NCT05649371
Access comprehensive clinical trial information for NCT05649371 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Calgary and is currently Not yet recruiting. The study focuses on Leukemia. Target enrollment is 60 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of Calgary
Timeline & Enrollment
N/A
Jan 01, 2023
Dec 01, 2024
Primary Outcome
Feasibility of Implementing an Exercise Program for Patients Undergoing Allogeneic-HSCT, Measured by Participant Attendance
Summary
The purpose of this study is to implement a prehabilitation intervention to enhance recovery
 for people undergoing allogeneic stem cell transplant for hematologic malignancies. All
 participants in this study will receive a prehabilation intervention in addition to usual
 care (no change to their chemotherapy protocols or transplant) and several quality of life
 and fitness scores will be measured throughout the intervention.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05649371
Non-Device Trial